Phase I/II study of intravesical epirubicin in patients with carcinoma in situ of the bladder.
Kurth
K H
KH
Dept. of Urology, University of Amsterdam, The Netherlands.
Mross
K
K
ten Kate
F
F
Weissglas
G
G
Carpentier
P J
PJ
Krueger
C G
CG
Blom
J
J
Groen
J M
JM
van Caubergh
R D
RD
van Aubel
O
O
D000283:Administration, Intravesical; D001706:Biopsy; D002278:Carcinoma in Situ / Q000188:drug therapy* / Q000473:pathology / Q000601:surgery; D003131:Combined Modality Therapy; D004341:Drug Evaluation; D015251:Epirubicin / Q000008:administration & dosage* / Q000009:adverse effects / Q000493:pharmacokinetics; D006801:Humans; D001749:Urinary Bladder Neoplasms / Q000188:drug therapy* / Q000473:pathology / Q000601:surgery
D015251:Epirubicin